SHAREHOLDER ALERT: Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the ...
September 19 2012 - 12:07PM
Business Wire
Levi & Korsinsky is investigating the Board of Directors of
Complete Genomics, Inc. (“Complete Genomics” or the “Company”)
(NasdaqGM: GNOM) for possible breaches of fiduciary duty and other
violations of state law in connection with the sale of the Company
to BGI-Shenzhen.
Click here to learn more about the investigation:
http://zlk.9nl.com/complete-genomics-gnom, or call:
877-363-5972. There is no cost or obligation to you.
Under the terms of the transaction, Complete Genomics
shareholders will receive $3.15 for each share of Complete Genomics
stock they own. The transaction has a total approximate value of
$117.6 million. The investigation concerns whether the Complete
Genomics Board of Directors breached their fiduciary duties to
Complete Genomics stockholders by failing to adequately shop the
Company before entering into this transaction and whether
BGI-Shenzhen is underpaying for Complete Genomics shares, thus
unlawfully harming Complete Genomics stockholders. In particular,
at least one analyst set a price target for Genomics stock at $5.00
per share.
If you own common stock in Complete Genomics and wish to obtain
additional information, please contact Joseph E. Levi, Esq. either
via email at jlevi@zlk.com or by telephone at (212) 363-7500,
toll-free: (877) 363-5972, or visit
http://zlk.9nl.com/complete-genomics-gnom.
Levi & Korsinsky is a national firm with offices in New York
and Washington D.C. The firm has extensive expertise in prosecuting
securities litigation involving financial fraud, representing
investors throughout the nation in securities and shareholder
lawsuits. For more information, please feel free to contact any of
the attorneys listed below. Attorney advertising. Prior results do
not guarantee similar outcomes.
Global X Genomics and Bi... (NASDAQ:GNOM)
Historical Stock Chart
From Sep 2024 to Oct 2024
Global X Genomics and Bi... (NASDAQ:GNOM)
Historical Stock Chart
From Oct 2023 to Oct 2024